The global market for liver transplants market is poised for significant growth, with a current market value expected to reach USD 1,409.8 million and projected to expand to approximately USD 2,653.4 million by 2033. This growth trajectory reflects a steady compound annual growth rate (CAGR) of 6.5% during the forecast period, driven by rising awareness of liver health and advancements in transplant technologies.
Liver transplants involve the surgical replacement of a diseased or failing liver with a healthy liver from a donor. The market’s expansion is fueled by increasing prevalence of liver diseases, including cirrhosis and liver cancer, and advancements in surgical techniques and immunosuppressive therapies enhancing transplant success rates.
Better surgical results and cutting-edge medical technologies are also fueling the market’s expansion, guaranteeing better patient care and long-term health advantages. The market for liver transplants is anticipated to have a substantial impact on healthcare, offering therapies that can save lives and improving the quality of life for a great number of people.
Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1281
The market for liver transplants is expected to develop in the near future, with improvements in treatment techniques expected to contribute significantly to this growth. The government’s and some private healthcare facilities’ reimbursement policies have led to an increase in the market for liver transplants.
Weforum (2022) reports that over 130,000 organ transplants were completed in 2020. The liver and heart were the next most common organs, after the kidney. A small number of companies that manufacture surgical instruments and preservation techniques control the majority of the liver transplant market.
For example, a group of Swiss doctors came up with a novel way in June 2022 to shorten the waiting list for organ transplants. In addition, the surgeons created a novel technique to sustain a damaged liver for a few days. In order to see encouraging progress, the staff is still keeping an eye on the patient.
The transplant waiting list may be shortened by developing new methods for storing injured livers as well as conducting efficient stem cell, tissue engineering, and organogenesis research and development.
Key Takeaways :
- The North American region showed a 29.2% share of the liver transplantation market.
- European nations also show promising market demand in the liver transplantation market, with a share of 20.7%.
- Based on treatment type, liver transplantation surgery dominates the liver transplantation market with a 61.1% global revenue share.
- According to the forecast, 51% of liver transplantation surgeries are done in hospitals, while the rest are done in ambulatory and adult liver transplantation centers.
Recent Developments Detected by FMI in the Liver Transplantation Market:
- In 2022, Jaslok Hospital and Research Center in Mumbai saved two lives with a single liver transplantation surgery. This transplantation surgery, also known as split cadaver liver donation surgery, is where the liver is split into two. It was then used by both an adult and a pediatric recipient simultaneously.
- In August 2022, Integrated Graphene, with a team of scientists, developed an electrochemical biosensor to detect biliary complications in donor livers. The device, Gii-Sens, can detect the quality of the liver before transplantation. It can prevent the development of biliary complications and match the donor-recipient for transplant. According to the makers of Gii-Sens, the device is portable, economical, and responds fast to point-of-care diagnostics.
Key Players:
- Allosource
- Conatus Pharmaceuticals Inc.
- Digna Biotech S.L.
- Dompe Farmaceutici S.p.A.
- Isogenis, Inc.
- RedHill Biopharma Ltd.
- Thompson Surgical
- Integra Life Sciences
- Baxter International Inc.
- XVIVO
- VirTech Bio
- Vital Therapies
- HepaTx
- Humedics
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-1281
Key Segments Profiled in the Global Liver Transplantation Market:
By Treatment Type:
- Liver Transplantation Surgery
- Post-Surgery Anti-Rejection Treatment
- Cyclosporine
- Tacrolimus
- Sirolimus Prednisone Azathioprine
- Mycophenolate Mofetil
By End Use:
- Hospitals
- Adult Liver Transplantation Centers
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East and Africa
Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/1281
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube